Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03206996 · ClinicalTrials.gov registry record · NA

Exposure Therapy for Auditory Sensitivity in Autism

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
5
Enrollment target

NCT03206996 is a NA study that has completed, run by University of Florida. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03206996, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

Auditory hyper-reactivity affects up to 66% of children with autism spectrum disorder (ASD) and has been linked to greater stress and anxiety for children and their families. Exposure and Response Prevention (E/RP) is highly effective for reducing obsessive/compulsive behaviors in children with both OCD and ASD. This study is the first to assess the feasibility and efficacy of E/RP for auditory sensory hyper-reactivity in ASD.

Interventions

  • BEHAVIORAL Exposure therapy
  • BEHAVIORAL Psycho-education
  • BEHAVIORAL Caregiver education/home program development

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2017-09-30
Est. Completion 2019-05-31
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT03206996

The ClinicalTrials.gov registry entry for NCT03206996 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Exposure therapy is the first listed.

NCT03206996 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03206996 about?

NCT03206996 is a clinical study titled "Exposure Therapy for Auditory Sensitivity in Autism". Auditory hyper-reactivity affects up to 66% of children with autism spectrum disorder (ASD) and has been linked to greater stress and anxiety for children and their families. Exposure and Response Prevention (E/RP) is highly effective for reducing obsessive/compulsive behaviors in children with both...

What is the current status of trial NCT03206996?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2017-09-30. Estimated completion is 2019-05-31.

What interventions are being tested in trial NCT03206996?

The interventions under investigation include: Exposure therapy (BEHAVIORAL), Psycho-education (BEHAVIORAL), Caregiver education/home program development (BEHAVIORAL).

Who is sponsoring clinical trial NCT03206996?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.